NEW DELHI: The Supreme Court on Tuesday expanded the scope of its misleading advertising case beyond Patanjali Ayurvedic products and against other FMCG companies that lured people to consume their products with deceptive promotions. It has sought answers from the Center and the states regarding the measures taken.
A bench of Justice Hima Kohli and Justice Asanuddin Amanullah also decided to consider the unethical practice of doctors prescribing expensive and unnecessary medicines to patients, and against Patanjali Ayurveda and its promoters. It requested the Indian Medical Association, the petitioner in the contempt suit, to: The hospital maintained order and demanded action against the erring doctor for the action taken against him.
IMA itself has been criticized in the past for favoring products from big pharmaceutical companies.
“What are you doing to suppress members of the association in the field of allopathic medicine? That is the question we need to ask you too,” the bench said, senior advocate PS Patwaria appearing for IMA told. “It’s not just that we have FMCG products, we have you and your members prescribing medicines based on recommendations that need valuable consideration…if that’s what’s happening. , why shouldn’t we beam at you?” ”
The court said FMCG companies cannot be allowed to “take on board” the people of this country, especially infants, children and the elderly who consume their products and are vulnerable to health risks. The court said it was more concerned about the health of ordinary people who fall prey to misleading advertisements, stating that the purpose was not to target anyone, but to send a message that breaking the law would not be tolerated. Ta.
“We are not here to attack any particular political party. The public’s greater concern is how they are misunderstood,” the court said. The group said the purpose of the lawsuit is to protect faceless people who ingest medicines and other products based on impressions created by misleading advertising.
As the scope of the case widened, the court also made the Center’s Consumer Affairs Department and the Ministry of Information and Broadcasting, along with licensing authorities of all states, party to the case under the Drugs and Magical Treatments (Offensive Advertisements) Act. He was arraigned as follows. Regulate drug advertising and ban advertising of drugs or treatments that claim to have magical properties.
The court directed all parties to submit responses regarding the actions they have taken in response to violations of the law over the past three years.
A bench of Justice Hima Kohli and Justice Asanuddin Amanullah also decided to consider the unethical practice of doctors prescribing expensive and unnecessary medicines to patients, and against Patanjali Ayurveda and its promoters. It requested the Indian Medical Association, the petitioner in the contempt suit, to: The hospital maintained order and demanded action against the erring doctor for the action taken against him.
IMA itself has been criticized in the past for favoring products from big pharmaceutical companies.
“What are you doing to suppress members of the association in the field of allopathic medicine? That is the question we need to ask you too,” the bench said, senior advocate PS Patwaria appearing for IMA told. “It’s not just that we have FMCG products, we have you and your members prescribing medicines based on recommendations that need valuable consideration…if that’s what’s happening. , why shouldn’t we beam at you?” ”
The court said FMCG companies cannot be allowed to “take on board” the people of this country, especially infants, children and the elderly who consume their products and are vulnerable to health risks. The court said it was more concerned about the health of ordinary people who fall prey to misleading advertisements, stating that the purpose was not to target anyone, but to send a message that breaking the law would not be tolerated. Ta.
“We are not here to attack any particular political party. The public’s greater concern is how they are misunderstood,” the court said. The group said the purpose of the lawsuit is to protect faceless people who ingest medicines and other products based on impressions created by misleading advertising.
As the scope of the case widened, the court also made the Center’s Consumer Affairs Department and the Ministry of Information and Broadcasting, along with licensing authorities of all states, party to the case under the Drugs and Magical Treatments (Offensive Advertisements) Act. He was arraigned as follows. Regulate drug advertising and ban advertising of drugs or treatments that claim to have magical properties.
Expanding
